1-9 of 9
Nancy Geller, PhD
Close
Sort by
Journal Articles

Comparison of Autologous Hematopoietic Cell Transplant (autoHCT), Bortezomib, Lenalidomide (Len) and Dexamethasone (RVD) Consolidation with Len Maintenance (ACM), Tandem Autohct with Len Maintenance (TAM) and Autohct with Len Maintenance (AM) for up-Front Treatment of Patients with Multiple Myeloma (MM): Primary Results from the Randomized Phase III Trial of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0702 - StaMINA Trial)

Edward A Stadtmauer, MD, Marcelo C. Pasquini, MD, Beth Blackwell, PhD, Kristin Knust, MS, Asad Bashey, MD PhD, Steven M. Devine, MD, Yvonne A Efebera, MD MPH, Siddhartha Ganguly, MD, Cristina Gasparetto, MD, Nancy Geller, PhD, Sergio A. Giralt, MD, Parameswaran Hari, MD MRCP, MS, Mary M. Horowitz, MD MS, John Koreth, MD, Heather Landau, Philip L. McCarthy, MD, Brian McClune, DO, Courtney Nelson, BS, BA, Muzaffar H. Qazilbash, MD, Nina Shah, MD, David H. Vesole, MD PhD, Ravi Vij, MD, Dan T. Vogl, MD, George Somlo, MD FACP, Amrita Krishnan, MD
Journal: Blood
Blood (2016) 128 (22): LBA-1.
https://doi.org/10.1182/blood.V128.22.LBA-1.LBA-1
Published: 2016
Journal Articles

Results of a Phase III Randomized, Multi-Center Study of Allogeneic Stem Cell Transplantation after High Versus Reduced Intensity Conditioning in Patients with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML): Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0901

Bart L Scott, MD, Marcelo C. Pasquini, MD, Brent Logan, PhD, Juan Wu, Steve Devine, MD, David L Porter, MD, Richard T. Maziarz, MD, Erica Warlick, MD, Hugo F. Fernandez, M.D., Edwin P. Alyea, MD, Mehdi Hamadani, MD, Asad Bashey, MD, PhD, Sergio A. Giralt, MD, Eric Leifer, PhD, Nancy Geller, PhD, Jennifer Le-Rademacher, PhD, Adam M. Mendizabal, PhD, Mary M. Horowitz, MD, MS, H. Joachim Deeg, MD, Mitchell E. Horwitz, MD
Journal: Blood
Blood (2015) 126 (23): LBA-8.
https://doi.org/10.1182/blood.V126.23.LBA-8.LBA-8
Published: 2015
Journal Articles

Tandem Autologous Hematopoietic Stem Cell Transplants (AuHCT) with or without Maintenance Therapy (auto-auto) Versus Single AuHCT Followed by HLA Matched Sibling Non- Myeloablative Allogeneic HCT (auto-allo) for Patients with Standard Risk (SR) Multiple Myeloma (MM): Results From the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0102 Trial

Amrita Krishnan, M.D., Marcelo C Pasquini, MD, MS, Marian Ewell, ScD, Edward A. Stadtmauer, MD, Edwin P Alyea, III, MD, Joseph H. Antin, MD, Raymond L. Comenzo, MD, Stacey Goodman, MD, Parameswaran Hari, MD, Robert Negrin, MD, Muzaffar H. Qazilbash, MD, Scott D Rowley, Firoozeh Sahebi, George Somlo, MD, David H. Vesole, MD, PhD, Dan T. Vogl, MD, MSCE, Daniel J. Weisdorf, MD, Nancy Geller, PhD, Mary M. Horowitz, MD, MS, Sergio Giralt, MD, David G. Maloney
Journal: Blood
Blood (2010) 116 (21): 41.
https://doi.org/10.1182/blood.V116.21.41.41
Published: 2010
Journal Articles

Long-Term Follow-up of Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Severe Paroxysmal Nocturnal Hemoglobinuria

Jeremy Pantin, MD, Xin Tian, Nancy Geller, PhD, Catalina Ramos, CRN, Lisa Cook, CRN, Sophia Grasmeder, CRN, Philip Scheinberg, MD, Neal S. Young, MD, Sumithira Vasu, MD, Theresa Donohue, MHS, PA-C, Richard Childs, MD
Journal: Blood
Blood (2010) 116 (21): 3505.
https://doi.org/10.1182/blood.V116.21.3505.3505
Published: 2010
Journal Articles

Tandem Autologous Stem Cell Transplants (auto-auto) with or without Maintenance Therapy Versus Single Autologous Transplant Followed by HLA-Matched Sibling Non- Myeloablative Allogeneic Stem Cell Transplant (auto-allo) for Patients (pts) with High Risk (HR) Multiple Myeloma (MM): Results From the Blood and Marrow Transplant Clinical Trials Network (BMT-CTN) 0102 Trial

Edward A Stadtmauer, MD, Amrita Krishnan, M.D., Marcelo C Pasquini, MD, MS, Marian Ewell, ScD, Edwin P Alyea, III, MD, Joseph H. Antin, MD, Hugo Castro-Malaspina, MD, Adetola A. Kassim, MD, MS, Robert Negrin, MD, Muzaffar H. Qazilbash, MD, J. Douglas Rizzo, MD, MS, Scott D Rowley, Firoozeh Sahebi, George Somlo, MD, David H. Vesole, MD, PhD, Dan T. Vogl, MD, MSCE, Daniel J. Weisdorf, MD, Nancy Geller, PhD, Mary M. Horowitz, MD, MS, David G. Maloney, Sergio Giralt, MD
Journal: Blood
Blood (2010) 116 (21): 526.
https://doi.org/10.1182/blood.V116.21.526.526
Published: 2010
Journal Articles

Biologic Assignment Clinical Trials in Hematopoietic Stem Cell Transplantation (HSCT) for Multiple Myeloma: Baseline Characteristics by Treatment Allocation from BMT CTN 0102 According to Availability of an HLA-Matched Sibling Donor.

Marcelo C. Pasquini, MD, MS, Marian Ewell, PhD, Edward A. Stadtmauer, MD, Christopher N. Bredeson, MD, MSc, FRCPC, Edwin P. Alyea, MD, Keith Stockerl-Goldstein, MD, Amrita Krishnan, MD, Firoozeh Sahebi, MD, Scott D. Rowley, MD, David G. Maloney, MD, David H. Vesole, MD, PhD, Mary M. Horowitz, MD, MS, Shelly Carter, PhD, Nancy Geller, PhD, Sergio Giralt, MD, Blood Marrow Transplant Clinical Trials Network (BMT CTN)
Journal: Blood
Blood (2007) 110 (11): 3028.
https://doi.org/10.1182/blood.V110.11.3028.3028
Published: 2007
Journal Articles

A Pilot Study Evaluating the CD34+ Cell Mobilizing Activity and Adverse Events Associated with Escalating Doses of AMD3100 in Healthy Volunteers.

Steven J. Lemery, MD, Matthew M. Hsieh, MD, Aleah Smith, Sheila Rao, Hanh M. Khuu, Donohue Theresa, PA, Jennifer M. Karpovich, NP, Lisa Cook, RN, Rose Goodwin, RN, Carol Boss, MPH, Gary Calandra, Nancy Geller, PhD, John Tisdale, MD, Richard Childs, MD
Journal: Blood
Blood (2007) 110 (11): 3278.
https://doi.org/10.1182/blood.V110.11.3278.3278
Published: 2007
Journal Articles

High Response Rates in Acute Steroid Refractory Graft-Versus-Host Disease (GVHD) Following Combined Tumor Necrosis Factor-alpha (TNF-α) and Interleukin-2 (IL-2) Blockade.

Ramaprasad Srinivasan, MD, PhD, Nancy Geller, PhD, Colleen Dorrance, MD, Igor Espinoza-Delgado, MD, A. John Barrett, MD, Yoshiyuki Takahashi, MD, PhD, Richard W. Childs, MD
Journal: Blood
Blood (2005) 106 (11): 1801.
https://doi.org/10.1182/blood.V106.11.1801.1801
Published: 2005
Journal Articles

Evaluation of Three Different Cyclosporine-Based Graft Versus Host Disease (GVHD) Prophylaxis Regimens Following Nonmyeloablative Hematopoietic Stem Cell Transplantation (NST).

Ramaprasad Srinivasan, MD, PhD, Nancy Geller, PhD, Sakti Chakrabarti, MD, Igor Espinoza-Delgado, MD, Teresa Donohue, Susan Leitman, MD, Charles D. Bolan, MD, Elizabeth J. Read, MD, John A. Barrett, MD, Richard W. Childs, MD
Journal: Blood
Blood (2004) 104 (11): 1236.
https://doi.org/10.1182/blood.V104.11.1236.1236
Published: 2004